<DOC>
	<DOCNO>NCT02480465</DOCNO>
	<brief_summary>Efficacy Safety Lobeglitazone versus Sitagliptin inadequately control Metformin alone Type 2 Diabetes mellitus Patients Metabolic syndrome .</brief_summary>
	<brief_title>Efficacy Safety Lobeglitazone Versus Sitagliptin</brief_title>
	<detailed_description>Efficacy Safety Lobeglitazone versus Sitagliptin inadequately control Metformin alone Type 2 Diabetes mellitus Patients Metabolic syndrome : 24-week , Multi-center , Randomized , Double-blind , Phase 4 Study .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>≥19 year old Waist line : male ≥ 90cm , female ≥ 85cm Applied 1 category list ( NCEPATP III ) 1 . SBP ≥ 130mmHg and/or DBP ≥ 85mmHg and/or take drug BP control 2 . HDLC : male &lt; 40mg/dl , female &lt; 50mg/dl and/or take drug HDLC increase 3 . TG ≥ 150mg/dl and/or take drug TG control At visit 1 : Applied 1 category list 1 . Type 2 DM Patients need stabilization period : 7 % ≤ HbA1c ≤ 10 % , treat Metformin ≥ 1000mg monotherapy least 12 week prior study → Visit 3 ( Randomization ) 2 . Type 2 DM Patients need stabilization period : 7 % ≤ HbA1c ≤ 10 % , treat Metformin ≥ 1000mg monotherapy least 12 week prior study ( Applied 1 category list ) ① Drug Naïve ② Taking Metformin &lt; 1000mg monotherapy and/or Taking Metformin &lt; 12 week prior study ③ Taking OHA At visit 2 ( After 12 week stabilization period ) : 7 % ≤ HbA1c ≤ 10 % Patients sign informed consent form Type 1 DM Patients secondary DM Patients ketoacidosis Patients take insulin &gt; 7 day within 12 week Hypersensitive biguanide and/or glitazone and/or DPP4inhibitor Patients take corticosteroid &gt; 7 day within 4 week Patients lactic acidosis Patients galactose intolerance and/or Lapp lactase deficiency and/or glucosegalactose malabsorption Patients innutrition and/or starvation and/or weakness and/or pituitary insufficiency and/or addisons disease History malignant tumor within 5 year History drug alcohol abuse within 12 week Patients congestive heart failure ( NYHA class III~IV ) uncontrolled arrythmia within 6 month Patients acute cardiovasvular disaese 12 week Applied 1 category list 1 . AST and/or ALT ≥ 3*ULN 2 . Serum creatinine : male ≥ 1.5mg/dl , female ≥ 1.4mg/dl 3 . Hb &lt; 10.5g/dl Women pregnant , breastfeed Childbearing age n't use adequate contraception Patients participate clinical trial Not eligible participate study discretion investigator</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>